Annual report [Section 13 and 15(d), not S-K Item 405]

Summary of Stock Option Activity (Details)

v3.26.1
Summary of Stock Option Activity (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]    
Number of shares, outstanding, balance 33,150  
Weighted average exercise price, outstanding, balance $ 142.71  
Weighted average remaining contractual term (in years), outstanding 9 years 10 months 20 days 6 years 8 months 19 days
Aggregate intrinsic value, outstanding, balance [1]  
Number of shares, granted 1,052,320  
Weighted average exercise price, granted $ 0.93  
Weighted average remaining contractual term (in years), granted 5 years 3 months  
Number of shares, forfeited (9,138)  
Weighted average exercise price, forfeited $ 105.90  
Number of shares, outstanding, balance 1,076,332  
Weighted average exercise price, outstanding, balance $ 4.41  
Aggregate intrinsic value, outstanding, balance [1]  
Number of shares, exercisable, balance 812,332  
Weighted average exercise price, exercisable, balance $ 5.54  
Weighted average remaining contractual term (in years), exercisable 9 years 10 months 13 days  
Aggregate intrinsic value, exercisable, balance [1]  
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock option awards and the closing market price of our common stock as of December 31, 2025, and 2024, respectively